Strength
75 mg/1
Manufacturer
Pfizer Inc.NDC
72618300002
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
RIMEGEPANT SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA212728On Market Since
3/5/2020
Pharmacological Classes
Calcitonin Gene-related Peptide Receptor Antagonist
Calcitonin Gene-related Peptide Receptor Antagonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
QULIPTA 10 MG TABLET
Brand
00074709530•AbbVie Inc.
$38.3668
per EA
QULIPTA 30 MG TABLET
Brand
00074709630•AbbVie Inc.
$38.4048
per EA
QULIPTA 60 MG TABLET
Brand
00074709430•AbbVie Inc.
$38.4749
per EA
UBRELVY 50 MG TABLET
Brand
00023649810•Allergan, Inc.
$109.0773
per EA
UBRELVY 100 MG TABLET
Brand
00023650110•Allergan, Inc.
$109.1882
per EA
UBRELVY 100 MG TABLET
Brand
00023650116•Allergan, Inc.
$109.1882
per EA
ZAVZPRET 10 MG NASAL SPRAY
Brand
00069350002•Pfizer Inc.
$190.1660
per EA